Form 4 for MDT Medtronic
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0001613103-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-23 | 2024-02-21 | MDT | Salmon Sean | EVP, Pres Cardiovascular | M - OptEx | $69.07 | +30.7K | 79.0K | +64% | +$2.12M |
| DM | 2024-02-23 | 2024-02-21 | MDT | Salmon Sean | EVP, Pres Cardiovascular | S - Sale+OE | $85.13 | -30.7K | 64.3K | -32% | -$2.61M |
| DM | 2024-02-23 | 2024-02-21 | MDT | Salmon Sean | EVP, Pres Cardiovascular | M - OptEx | $0.00 | -30.7K | 13.1K | -70% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-02-21 | M | A | 13,066 | $62.76 | 62,949 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-02-21 | M | A | 1,594 | $62.76 | 49,833 | D | — | — | (F1) Includes 186 units acquired through dividend reinvestment since the last report filed by the reporting person. |
| 3 | Common | Ordinary Shares | 2024-02-21 | M | A | 16,035 | $74.84 | 78,984 | D | — | — | |
| 4 | Common | Ordinary Shares | 2024-02-21 | S | D | 1,594 | $85.06 | 77,390 | D | — | — | |
| 5 | Common | Ordinary Shares | 2024-02-21 | S | D | 16,035 | $85.12 | 48,289 | D | — | — | (F3) The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.12 to $85.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. |
| 6 | Common | Ordinary Shares | 2024-02-21 | S | D | 13,066 | $85.15 | 64,324 | D | — | — | (F2) The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.15 to $85.18. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-02-21 | M | D | 16,035 | $0.00 | 0 | D | $74.84 · 2016-01-27 to 2025-01-27 | 16,035 Ordinary Shares | |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-02-21 | M | D | 13,066 | $0.00 | 0 | D | $62.76 · 2015-07-28 to 2024-07-28 | 13,066 Ordinary Shares | |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-02-21 | M | D | 1,594 | $0.00 | 13,066 | D | $62.76 · 2015-07-28 to 2024-07-28 | 1,594 Ordinary Shares |